Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources OfficerGlobeNewsWire • 01/25/23
Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public OfferingGlobeNewsWire • 01/25/23
An Unexpected Feat Just Sent Pliant Therapeutics Soaring More Than 50%Investors Business Daily • 01/23/23
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary FibrosisGlobeNewsWire • 01/22/23
Strength Seen in Pliant Therapeutics, Inc. (PLRX): Can Its 8.3% Jump Turn into More Strength?Zacks Investment Research • 01/12/23
Pliant Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/23
Pliant Therapeutics: Wait For More Data Clarity On Dose-Dependent Response In FVCSeeking Alpha • 12/16/22
Pliant Therapeutics Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary FibrosisGlobeNewsWire • 12/15/22
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/08/22
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/08/22
Pliant Therapeutics to Participate in the RBC Biotech Expert Insights Series: Pulmonary/Lung Disease Mini-SymposiumGlobeNewsWire • 10/05/22
Pliant Therapeutics Announces Appointment of Katharine Knobil, M.D. to Board of DirectorsGlobeNewsWire • 09/15/22
Has Pliant Therapeutics (PLRX) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 09/06/22
Pliant Therapeutics, Inc. (PLRX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 09/05/22
How Much Upside is Left in Pliant Therapeutics, Inc. (PLRX)? Wall Street Analysts Think 127%Zacks Investment Research • 09/01/22
Pliant Therapeutics Announces Positive DSMB Safety Review of INTEGRIS-IPF Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary FibrosisGlobeNewsWire • 09/01/22
How Much Upside is Left in Pliant Therapeutics, Inc. (PLRX)? Wall Street Analysts Think 106%Zacks Investment Research • 08/15/22